Literature DB >> 18446710

Are chronic dialysis patients at increased risk for cancer?

Sreedhar Mandayam1, Vahakn B Shahinian.   

Abstract

This review summarizes the plausible mechanisms of carcinogenesis, critically analyzes the literature on cancer risk and discusses issues of cancer screening in chronic dialysis patients. Despite conflicting results among various studies, there is sufficient evidence to conclude that there is a heightened incidence of at least some cancers in dialysis patients. The data most convincingly support an increased risk of genitourinary malignancies. Screening for the common solid organ cancers (prostate, colon, breast and cervix) should be individualized, and is appropriate only for the minority of patients with a life expectancy on dialysis of 10 years or longer. Further research is needed before routine screening for bladder or renal cell cancers can be recommended.

Entities:  

Mesh:

Year:  2008        PMID: 18446710

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  21 in total

Review 1.  Chronic kidney disease and cancer: a troubling connection.

Authors:  Benedicte Stengel
Journal:  J Nephrol       Date:  2010 May-Jun       Impact factor: 3.902

2.  Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.

Authors:  Alberto Breda; Giuseppe Lucarelli; Giuseppe Luccarelli; Oscar Rodriguez-Faba; Luis Guirado; Carmen Facundo; Carlo Bettocchi; Loreto Gesualdo; Giuseppe Castellano; Giuseppe Grandaliano; Michele Battaglia; Juan Palou; Pasquale Ditonno; Humberto Villavicencio
Journal:  World J Urol       Date:  2014-02-07       Impact factor: 4.226

3.  Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.

Authors:  Weifeng Shang; Liu Huang; Li Li; Xiaojuan Li; Rui Zeng; Shuwang Ge; Gang Xu
Journal:  Mol Clin Oncol       Date:  2016-07-07

4.  Estimated radiation exposure from medical imaging in hemodialysis patients.

Authors:  Andreana De Mauri; Marco Brambilla; Doriana Chiarinotti; Roberta Matheoud; Alessandro Carriero; Martino De Leo
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

Review 5.  Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.

Authors:  Zeba Khan; Manoj Pandey; Ravindra M Samartha
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

Review 6.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

7.  Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis.

Authors:  S-L Liu; L Qi; W-Q Han; B-S Zhu; X Zhou; S-S Jiang; M-F Chen; Y Li; W He; L-F Liu; X-H Hu; Y Xie; F-H Zeng; X-B Zu
Journal:  Clin Transl Oncol       Date:  2015-07-29       Impact factor: 3.405

Review 8.  Role of vitamin D in chronic kidney disease.

Authors:  Tejas V Patel; Ajay K Singh
Journal:  Semin Nephrol       Date:  2009-03       Impact factor: 5.299

9.  Radiation exposure from medical imaging in dialyzed patients undergoing renal pre-transplant evaluation.

Authors:  Andreana De Mauri; Roberta Matheoud; Alessandro Carriero; Domenico Lizio; Doriana Chiarinotti; Marco Brambilla
Journal:  J Nephrol       Date:  2016-03-02       Impact factor: 3.902

10.  [Malignant neoplasms and kidney transplantation].

Authors:  H Heynemann; A Hamza; S Wagner; R Hoda; A Schumann; P Fornara
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.